These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28785079)

  • 1. Short-term treatment with eicosapentaenoic acid improves inflammation and affects colonic differentiation markers and microbiota in patients with ulcerative colitis.
    Prossomariti A; Scaioli E; Piazzi G; Fazio C; Bellanova M; Biagi E; Candela M; Brigidi P; Consolandi C; Balbi T; Chieco P; Munarini A; Pariali M; Minguzzi M; Bazzoli F; Belluzzi A; Ricciardiello L
    Sci Rep; 2017 Aug; 7(1):7458. PubMed ID: 28785079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis.
    Scaioli E; Sartini A; Bellanova M; Campieri M; Festi D; Bazzoli F; Belluzzi A
    Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1268-1275.e2. PubMed ID: 29391271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota.
    Piazzi G; D'Argenio G; Prossomariti A; Lembo V; Mazzone G; Candela M; Biagi E; Brigidi P; Vitaglione P; Fogliano V; D'Angelo L; Fazio C; Munarini A; Belluzzi A; Ceccarelli C; Chieco P; Balbi T; Loadman PM; Hull MA; Romano M; Bazzoli F; Ricciardiello L
    Int J Cancer; 2014 Nov; 135(9):2004-13. PubMed ID: 24676631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
    Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
    Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission.
    Xu AT; Li Y; Zhao D; Shen J; Xu XT; Qiao YQ; Zhu MM; Wang TR; Cui Y; Ai LY; Ran ZH
    Inflamm Bowel Dis; 2015 Feb; 21(2):241-50. PubMed ID: 25545374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.
    Li Y; de Haar C; Chen M; Deuring J; Gerrits MM; Smits R; Xia B; Kuipers EJ; van der Woude CJ
    Gut; 2010 Feb; 59(2):227-35. PubMed ID: 19926618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gegen Qinlian decoction maintains colonic mucosal homeostasis in acute/chronic ulcerative colitis via bidirectionally modulating dysregulated Notch signaling.
    Zhao Y; Luan H; Gao H; Wu X; Zhang Y; Li R
    Phytomedicine; 2020 Mar; 68():153182. PubMed ID: 32065953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inulin-type fructans improve active ulcerative colitis associated with microbiota changes and increased short-chain fatty acids levels.
    Valcheva R; Koleva P; Martínez I; Walter J; Gänzle MG; Dieleman LA
    Gut Microbes; 2019; 10(3):334-357. PubMed ID: 30395776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of highly purified eicosapentaenoic acid on erythrocyte fatty acid composition and leukocyte and colonic mucosa leukotriene B4 production in children with ulcerative colitis.
    Shimizu T; Fujii T; Suzuki R; Igarashi J; Ohtsuka Y; Nagata S; Yamashiro Y
    J Pediatr Gastroenterol Nutr; 2003 Nov; 37(5):581-5. PubMed ID: 14581801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.
    Mak WY; Buisson A; Andersen MJ; Lei D; Pekow J; Cohen RD; Kahn SA; Pereira B; Rubin DT
    Dig Dis Sci; 2018 May; 63(5):1294-1301. PubMed ID: 29468374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal level of calprotectin identifies histologic inflammation in patients with ulcerative colitis in clinical and endoscopic remission.
    Guardiola J; Lobatón T; Rodríguez-Alonso L; Ruiz-Cerulla A; Arajol C; Loayza C; Sanjuan X; Sánchez E; Rodríguez-Moranta F
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1865-70. PubMed ID: 24993368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased suppressor of cytokine signaling-3 expression predicts mucosal relapse in ulcerative colitis.
    Li Y; Nuij VJ; Baars JE; Biermann K; Kuipers EJ; Peppelenbosch MP; de Haar C; Janneke van der Woude C
    Inflamm Bowel Dis; 2013 Jan; 19(1):132-40. PubMed ID: 22535619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
    World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative Colitis.
    Theede K; Holck S; Ibsen P; Ladelund S; Nordgaard-Lassen I; Nielsen AM
    Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1929-36.e1. PubMed ID: 26051392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis.
    Carlsen K; Riis LB; Elsberg H; Maagaard L; Thorkilgaard T; Sørbye SW; Jakobsen C; Wewer V; Florholmen J; Goll R; Munkholm P
    Scand J Gastroenterol; 2018; 53(7):825-830. PubMed ID: 29968483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of fecal calprotectin for the early prediction of short-term outcomes of remission-induction treatments in ulcerative colitis in comparison with two-item patient-reported outcome.
    Toyonaga T; Kobayashi T; Nakano M; Saito E; Umeda S; Okabayashi S; Ozaki R; Hibi T
    PLoS One; 2017; 12(9):e0185131. PubMed ID: 28934315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of hath1 gene expression directly regulated by hes1 via notch signaling is associated with goblet cell depletion in ulcerative colitis.
    Zheng X; Tsuchiya K; Okamoto R; Iwasaki M; Kano Y; Sakamoto N; Nakamura T; Watanabe M
    Inflamm Bowel Dis; 2011 Nov; 17(11):2251-60. PubMed ID: 21987298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.
    Lee SH; Kim MJ; Chang K; Song EM; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD
    BMC Gastroenterol; 2017 Oct; 17(1):110. PubMed ID: 29061121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
    Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
    Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal calprotectin level correlated with both endoscopic severity and disease extent in ulcerative colitis.
    Kawashima K; Ishihara S; Yuki T; Fukuba N; Oshima N; Kazumori H; Sonoyama H; Yamashita N; Tada Y; Kusunoki R; Oka A; Mishima Y; Moriyama I; Kinoshita Y
    BMC Gastroenterol; 2016 Apr; 16():47. PubMed ID: 27071448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.